Attgeno

– Supernitro – New Unique Drug Against Acute Pulmonary Hypertension

Acute pulmonary hypertension is a major cause of death in conditions such as pulmonary embolism, sepsis and after major surgery and there is a great need for selective, safe and efficacious vasodilator-treatment. Attgeno AB develops novel nitric oxide donators which are selective for the pulmonary circulation, making them safe and without systemic side-effects.